BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 961741)

  • 21. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives.
    Hayashi M; Saruta T; Nakamura R; Saito I; Kondo K; Kato E
    Gynecol Obstet Invest; 1979; 10(5):246-53. PubMed ID: 395034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension and oral contraceptives.
    Oparil S
    J Cardiovasc Med; 1981 Apr; 6(4):381, 384-7. PubMed ID: 12263383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of arterial hypertension imputable to an estroprogestational contraceptive. Implication of the renin-angiotensin-aldosterone system].
    Fontenaille C; Camelot G; Béquart P; Boulangé M
    J Urol Nephrol (Paris); 1969 Dec; 75(12):950-5. PubMed ID: 4314141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of plasma renin substrate by radioimmunoassay of angiotensin. I. Concentration in syndromes associated with steroid excess.
    Krakoff LR
    J Clin Endocrinol Metab; 1973 Jul; 37(1):110-7. PubMed ID: 4351771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antihypertensive drugs on the renin-angiotensin system.
    Johnston CI
    Drugs; 1976; 12(4):274-91. PubMed ID: 786609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hormonal contraception and hypertension].
    Hamann KM; Faulhaber HD; Hamann B
    Z Arztl Fortbild (Jena); 1982 Mar; 76(5):198-201. PubMed ID: 7080544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pathogenesis of oral contraceptive hypertension (author's transl)].
    Girndt J; Scheler F
    Klin Wochenschr; 1977 Apr; 55(7):347-8. PubMed ID: 870746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple arterial occlusions and hypertension probably caused by an oral contraceptive: a patient in whom the development of renovascular hypertension has been followed.
    Delin K; Aurell M; Claes G; Teger-Nilsson AC; Wallentin I
    Clin Nephrol; 1976 Oct; 6(4):453-7. PubMed ID: 788979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives.
    De Leo V; la Marca A; Morgante G; Lucani B; Nami R; Ciotta L; Cianci A; Petraglia F
    Contraception; 2001 Sep; 64(3):145-8. PubMed ID: 11704092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications and contraindications of oral contraception.
    Beck WW
    Clin Obstet Gynecol; 1981 Sep; 24(3):893-901. PubMed ID: 7026110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma renin activity, reactivity, concentration and substrate following hypertension during pregnancy. Effect of oral contraceptive agents.
    Kotchen TA; Kotchen JM; Guthrie GP; Cottrill CM
    Hypertension; 1979; 1(4):355-61. PubMed ID: 396239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Internal medicine problems regarding contraception. Part I].
    Mall-Haefeli M
    Schweiz Med Wochenschr; 1980 Sep; 110(36):1314-9. PubMed ID: 7444416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during menstrual cycles controlled by oral contraceptive preparations.
    Johnson IR
    Br J Obstet Gynaecol; 1980 Oct; 87(10):883-8. PubMed ID: 7000163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The choice of oral contraception in 1984: general indications and specific cases].
    Gaspard U
    Rev Med Liege; 1984 Apr; 39(7):261-5. PubMed ID: 6729293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
    Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
    Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hypertension with irreversible renal failure due to oral contraceptives.
    Zech P; Rifle G; Lindner A; Sassard J; Blanc-Brunat N; Traeger J
    Br Med J; 1975 Nov; 4(5992):326-7. PubMed ID: 1192051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents.
    Gordon EM; Douglas J; Ratnoff OD
    J Clin Invest; 1983 Nov; 72(5):1833-8. PubMed ID: 6355187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.